September 18, 2007
Quick Study | Does a common treatment for prostate cancer increase the risk of diabetes and heart disease?
THE QUESTION: Does a common treatment for prostate cancer increase the risk of diabetes and heart disease? THE CONTEXT: Drugs such as Lupron and Zoladex, known as gonadotropin-releasing hormone (GnRH) agonists, are a common treatment for advanced prostate cancer, and are becoming more popular for men with less advanced disease.
More: continued here





















Leave a comment